Previous Article | Next Article ![]()
Infection and Immunity, November 1999, p. 5579-5586, Vol. 67, No. 11
Laboratory of Parasitology,
Received 11 May 1999/Returned for modification 22 June
1999/Accepted 9 August 1999
To better understand the role of tumor necrosis factor (TNF) during
Trypanosoma cruzi infection in BALB/c mice, we have
investigated the kinetics of circulating tumor necrosis factor (TNF),
soluble TNF receptor 1 (sTNR1), and sTNFR2 levels, as well as the
interactions between such factors, in relation to parasitemia,
cachexia, and mortality of acutely infected animals. Our data show that
the parasitemic phase of T. cruzi infection in mice is
associated with high levels of circulating TNF and sTNFR2, resulting in
the formation of cytokine-receptor complexes and some degree of
neutralization of TNF bioactivity. Although sTNR2 levels always
exceeded TNF levels, low sTNFR/TNF circulating ratios were associated
with cachexia in all infected mice, whereas the lowest ratios were observed in dying animals harboring the highest parasitemia. We also
studied the modulation of sTNFR/TNF ratios induced by anti-TNF antibodies administered to infected animals and their consequences on
the outcome of the infection. The injection of anti-TNF monoclonal antibody (MAb) TN3 into infected mice resulted in a paradoxical overproduction of TNF (associated with a higher parasitemia), lowered
the sTNFR/TNF circulating ratios, and considerably worsened cachexia
and mortality of animals. Another anti-TNF MAb (1F3F3) decreased the in
vivo availability of TNF as well as parasite levels and reduced
cachexia. Altogether, such results highlight that, besides playing a
beneficial role early in infection, TNF also triggers harmful effects
in the parasitemic phase, which are limited by the in vivo simultaneous
endogenous production of soluble receptors.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Endogenous Balance of Soluble Tumor Necrosis Factor Receptors
and Tumor Necrosis Factor Modulates Cachexia and Mortality in Mice
Acutely Infected with Trypanosoma cruzi

*
Corresponding author. Mailing address: Laboratoire de
Parasitologie, Faculté de Médecine, ULB, Route de Lennik
808, CP 616, B-1070 Brussels, Belgium. Phone: 32 2 555 62 55. Fax: 32 2 555 61 28. E-mail: ycarlier{at}ulb.ac.be.
Present address: Department of Pharmacology, University Medical
Centre of Geneva, Geneva, Switzerland.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»